The latest market
report published by Credence Research, Inc. “Bioanalytical
Testing Services Market-
Growth, Future Prospects, Competitive Analysis, 2018 -
2026,” the global bioanalytical testing services market was valued at
US$ 2,393.9 Mn in 2017 and expected to reach US$ 4,793.1 Mn by 2026, expanding
at a CAGR of 7.8% from 2018 to 2026.
Browse the full report Bioanalytical Testing
Services Industry 2018 – 2026 at https://www.credenceresearch.com/report/bioanalytical-testing-services-market
Market Insights
Bioanalysis refers
to the collection of scientific methods allowing quantitative determination of
entities and biomarkers. Bioanalytical tests assist in reducing the gap between
drug administration during clinical and preclinical trials and the
interpretation of data for drug pharmacodynamics and pharmacokinetics.
Bioanalytical testing services providers offer bioanalysis tests to medical
research, biotechnology and pharmaceutical companies and institutions engaged
in drug research and development.
This industry is
fragmented among several niche vendors and is led by a limited number of large
players that provide holistic services. Industry experts opine that the
prevailing trends in the pharmaceutical and biotechnology industries indicate
an increasing emphasis towards outsourcing of research activities as
manufacturers and drug developers seek to reduce the internal resources and
expenditure for research models for higher accountability to meet their drug
development and manufacturing requirements.
Download Sample research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/59645
At present,
regulatory operations have become a prominent challenge for several
pharmaceutical companies as a majority of these companies face cost and labor
pressures. Manufacturers are struggling to procure new product approvals,
maintain compliance while assuring competitive operation cost. Furthermore,
high investments in regulatory information systems and labor have increased the
overall operation cost. This has led pharmaceutical companies to opt for
sustainable outsourcing of research and development activities.
To sum up, some of
the prominent factors that support increasing outsourcing of bioanalytical
testing activities are increase in the number of potential new drug candidates,
need for fast drug development process, growing cost pressures of introducing
new drugs, rapid patent expirations, and growing demand for unique technical
expertise. Large molecule segment is expected to witness rapid market growth
during the forecast period, while North America is the largest regional market
for bioanalytical testing services. The dominant position of North America,
however, will be significantly challenged by the rapid progress of outsourcing
hubs in Asia Pacific.
Key Market Movements:
- Low cost of efficient outsourcing
services in Asia Pacific to attract influx of service contracts from North
America and Western Europe
- Increasing potential drug pipeline along
with growing need for rapid product approvals to ensure competitive edge
Do inquiry before purchase the Industry Research Report @
https://www.credenceresearch.com/inquiry-before-buying/59645
TOC :
Chapter 4. Global Bioanalytical Testing Services Market,
by Molecule Type, 2016 - 2026 (US$ Mn)
4.1. Overview
4.2. Small Molecule
4.3. Large Molecule
4.3.1. Large Molecule LC-MS Test
4.3.2. Immunoassays
4.3.2.1. Pharmacokinetics (PK)
4.3.2.2. Anti-drug Antibody Tests
4.3.2.3. Other Immunoassay Tests
4.3.3. Others
4.1. Overview
4.2. Small Molecule
4.3. Large Molecule
4.3.1. Large Molecule LC-MS Test
4.3.2. Immunoassays
4.3.2.1. Pharmacokinetics (PK)
4.3.2.2. Anti-drug Antibody Tests
4.3.2.3. Other Immunoassay Tests
4.3.3. Others
Chapter 5. Global Bioanalytical Testing Services Market,
by Test Type, 2016 - 2026 (US$ Mn)
5.1. Overview
5.2. ADME Testing
5.3. Pharmacodynamics (PD) Testing
5.4. Pharmacokinetics (PK) Testing
5.5. Bioavailability Testing
5.6. Bioequivalence Testing
5.7. Others
5.1. Overview
5.2. ADME Testing
5.3. Pharmacodynamics (PD) Testing
5.4. Pharmacokinetics (PK) Testing
5.5. Bioavailability Testing
5.6. Bioequivalence Testing
5.7. Others
Chapter 6. Global Bioanalytical Testing Services Market,
by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America Bioanalytical Testing Services Market, 2016 - 2026 (US$ Mn)
6.2.1. North America Bioanalytical Testing Services Market, by Molecule Type, 2016 - 2026 (US$ Mn)
6.2.2. North America Bioanalytical Testing Services Market, by Test Type, 2016 - 2026 (US$ Mn)
6.2.3. North America Bioanalytical Testing Services Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Bioanalytical Testing Services Market, 2016 – 2026 (US$ Mn)
6.3.1. Europe Bioanalytical Testing Services Market, by Molecule Type, 2016 - 2026 (US$ Mn)
6.3.2. Europe Bioanalytical Testing Services Market, by Test Type, 2016 - 2026 (US$ Mn)
6.3.3. Europe Bioanalytical Testing Services Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. France
6.3.3.4. Italy
6.3.3.5. Rest of Europe
6.4. Asia Pacific Bioanalytical Testing Services Market, 2016 – 2026 (US$ Mn)
6.4.1. Asia Pacific Bioanalytical Testing Services Market, by Molecule Type, 2016 - 2026 (US$ Mn)
6.4.2. Asia Pacific Bioanalytical Testing Services Market, by Test Type, 2016 - 2026 (US$ Mn)
6.4.3. Asia Pacific Bioanalytical Testing Services Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. India
6.4.3.4. Australia
6.4.3.5. Rest of Asia Pacific
6.5. Latin America Bioanalytical Testing Services Market, 2016 – 2026 (US$ Mn)
6.5.1. Latin America Bioanalytical Testing Services Market, by Molecule Type, 2016 - 2026 (US$ Mn)
6.5.2. Latin America Bioanalytical Testing Services Market, by Test Type, 2016 - 2026 (US$ Mn)
6.5.3. Latin America Bioanalytical Testing Services Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa Bioanalytical Testing Services Market, 2016 – 2026 (US$ Mn)
6.6.1. Middle East & Africa Bioanalytical Testing Services Market, by Molecule Type, 2016 - 2026 (US$ Mn)
6.6.2. Middle East & Africa Bioanalytical Testing Services Market, by Test Type, 2016 - 2026 (US$ Mn)
6.6.3. Middle East & Africa Bioanalytical Testing Services Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. South Africa
6.6.3.3. Rest of Middle East & Africa
6.1. Overview
6.2. North America Bioanalytical Testing Services Market, 2016 - 2026 (US$ Mn)
6.2.1. North America Bioanalytical Testing Services Market, by Molecule Type, 2016 - 2026 (US$ Mn)
6.2.2. North America Bioanalytical Testing Services Market, by Test Type, 2016 - 2026 (US$ Mn)
6.2.3. North America Bioanalytical Testing Services Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Bioanalytical Testing Services Market, 2016 – 2026 (US$ Mn)
6.3.1. Europe Bioanalytical Testing Services Market, by Molecule Type, 2016 - 2026 (US$ Mn)
6.3.2. Europe Bioanalytical Testing Services Market, by Test Type, 2016 - 2026 (US$ Mn)
6.3.3. Europe Bioanalytical Testing Services Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. France
6.3.3.4. Italy
6.3.3.5. Rest of Europe
6.4. Asia Pacific Bioanalytical Testing Services Market, 2016 – 2026 (US$ Mn)
6.4.1. Asia Pacific Bioanalytical Testing Services Market, by Molecule Type, 2016 - 2026 (US$ Mn)
6.4.2. Asia Pacific Bioanalytical Testing Services Market, by Test Type, 2016 - 2026 (US$ Mn)
6.4.3. Asia Pacific Bioanalytical Testing Services Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. India
6.4.3.4. Australia
6.4.3.5. Rest of Asia Pacific
6.5. Latin America Bioanalytical Testing Services Market, 2016 – 2026 (US$ Mn)
6.5.1. Latin America Bioanalytical Testing Services Market, by Molecule Type, 2016 - 2026 (US$ Mn)
6.5.2. Latin America Bioanalytical Testing Services Market, by Test Type, 2016 - 2026 (US$ Mn)
6.5.3. Latin America Bioanalytical Testing Services Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa Bioanalytical Testing Services Market, 2016 – 2026 (US$ Mn)
6.6.1. Middle East & Africa Bioanalytical Testing Services Market, by Molecule Type, 2016 - 2026 (US$ Mn)
6.6.2. Middle East & Africa Bioanalytical Testing Services Market, by Test Type, 2016 - 2026 (US$ Mn)
6.6.3. Middle East & Africa Bioanalytical Testing Services Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. South Africa
6.6.3.3. Rest of Middle East & Africa
Chapter 7. Company Profiles
7.1. IQVIA
7.1.1. Company Overview
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. PAREXEL International
7.3. Tandem Labs Inc.
7.4. Pharmaceutical Product Development, LLC
7.5. Covance Inc.
7.6. Celerion Inc.
7.7. Eurofins Scientific
7.1. IQVIA
7.1.1. Company Overview
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. PAREXEL International
7.3. Tandem Labs Inc.
7.4. Pharmaceutical Product Development, LLC
7.5. Covance Inc.
7.6. Celerion Inc.
7.7. Eurofins Scientific